WASHINGTON, D.C. — A seismic shift in pediatric medical care has arrived with the FDA’s approval ... marks the first-ever approval of a mesenchymal stromal cell (MSC) therapy in the United ...

Stem cell therapy aims to reboot the immune system and prevent MS attacks. Though it shows promise and is available through clinical trials, it’s not FDA-approved to treat MS. If you’re ...

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's cell therapy for treating a type of complication that occurs after a stem cell ... The FDA advises the treating ...

An FDA advisory panel vote of 9-1 to recommend the approval of Mesoblast Limited’s graft versus host disease (GVHD) cell therapy was a cruel tease for the Australian company. More than four ...

Allogeneic stem cell therapy allows "off the shelf" cells ... the next major milestone will be FDA approval. In March this year the company received feedback from the FDA about its trial design ...

Incyte and Syndax Pharmaceutical said the Food and Drug Administration approved their graft disease treatment Niktimvo antibody in nine milligram and 22 milligram vial sizes.

Ryoncil is the first FDA-approved MSC therapy. It contains MSCs ... as a complication of allogeneic hematopoietic (blood) stem cell transplantation (allo-HSCT). In allo-HSCT, a patient receives ...

CellTrans has claimed the first FDA approval for a cell therapy used to treat type 1 diabetes, consisting of insulin-producing islet beta cells taken from deceased donors. The Chicago-based ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Ryoncil is the first FDA-approved mesenchymal stromal cell (MSC) therapy. It contains MSCs ... of allogeneic hematopoietic (blood) stem cell transplantation (allo-HSCT). In allo-HSCT, a patient ...